Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
A Multiphase Optimization Strategy to Enhance Diabetes Management Interventions for Patients With Uncontrolled Diabetes
University of Wisconsin, Madison
376 participants
Feb 3, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults. Participants will be assigned to one of 4 groups, and will either: * receive care as usual; or, * receive added medicine management support from a pharmacist; or, * receive support from a Community Health Worker (CHW) to address life challenges; or, * receive both the pharmacist medicine management and the CHW support
Eligibility
Inclusion Criteria6
- Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish.
- Taking at least one oral or injectable diabetes medication
- HbA1c ≥ 7.5% based on point of care test.
- Will reside in the geographical area throughout the study period.
- Have access to a phone during the study period.
- Willing to attend all orientation/training sessions.
Exclusion Criteria4
- Having a caregiver who is the main decision maker in self-management.
- Participating in another lifestyle, or medication adherence program.
- Participated in standard MTM/MTM-related intervention in the last 6 months.
- Women who are pregnant or plan to get pregnant in the next 6 months.
Interventions
Participants will receive added medicine management support from a pharmacist. This will involve one 60-minute session with the pharmacist either in-person or over the phone and at least four 30-minute follow-up sessions with the pharmacist over the phone.
Participants will receive support from a Community Health Worker (CHW) to address life challenges that might be affecting their health and diabetes and to discuss diabetes beliefs and concerns. This will involve one \~30-minute phone call with the CHW to discuss needs and a 2-hour session with the CHW in-person for a comprehensive assessment. Participants will also receive \~10, 15 to 30-minute calls from the CHW to discuss diabetes beliefs and concerns.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05912647